Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

257 Articles

Lee Jackson | Dec 12, 2016 at 8:20 AM EST

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political…

Jon C. Ogg | Nov 29, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson…

Jon C. Ogg | Oct 24, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Ariad Pharmaceuticals, Comcast, ConEd, Electronic Arts, Kinder Morgan,…

Lee Jackson | Oct 6, 2016 at 9:50 AM EDT

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among…

Chris Lange | Sep 14, 2016 at 8:20 AM EDT

Key FDA Decisions and Trial Results Coming in the Next 2 Months

24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in…

Chris Lange | Sep 2, 2016 at 7:40 AM EDT

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | May 25, 2016 at 9:40 AM EDT

5 Major Clinical Trial Results Coming Up

24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in…

Chris Lange | May 1, 2016 at 10:15 AM EDT

How Analysts View Vertex After Earnings

One portfolio manager on CNBC noted that Vertex could end up being an acquisition target ahead, without mentioning any specifics.

Jon C. Ogg | Apr 28, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Facebook, First Solar, Hess, Texas Instruments, U.S. Steel,…

Lee Jackson | Apr 12, 2016 at 8:25 AM EDT

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

A new Jefferies research report highlights their top growth picks for this week, and the list is dominated by top…

Lee Jackson | Apr 7, 2016 at 10:10 AM EDT

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

Sometimes after a stock has a good run, the analysts on Wall Street start to get a little gun-shy, especially…

Chris Lange | Apr 6, 2016 at 10:05 AM EDT

5 Biotechs With the Most Upside This Earnings Cycle

Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help…

Chris Lange | Mar 29, 2016 at 9:35 AM EDT

8 Major Biopharma Events Coming Later in 2016 and in 2017

FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in…

1 … 7 8 9 10 11 … 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Key FDA Decisions and Trial Results Coming in the Next 2 Months

8 Major FDA Decisions and Trial Results to Watch for in September

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

5 Major Clinical Trial Results Coming Up

How Analysts View Vertex After Earnings

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

5 Biotechs With the Most Upside This Earnings Cycle

8 Major Biopharma Events Coming Later in 2016 and in 2017

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Key FDA Decisions and Trial Results Coming in the Next 2 Months

8 Major FDA Decisions and Trial Results to Watch for in September

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

5 Major Clinical Trial Results Coming Up

How Analysts View Vertex After Earnings

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

5 Biotechs With the Most Upside This Earnings Cycle

8 Major Biopharma Events Coming Later in 2016 and in 2017

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Featured Reads

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62